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ABSTRACT
Objectives: Multimorbidity, defined as the presence
of 2 or more chronic medical conditions in an
individual, is associated with poorer health outcomes.
Several multimorbidity measures exist, and the
challenge is to decide which to use preferentially in
predicting health outcomes. The study objective was to
compare the performance of 5 count-based
multimorbidity measures in predicting emergency
hospital admission and functional decline in older
community-dwelling adults attending primary care.
Setting: 15 general practices (GPs) in Ireland.
Participants: n=862, ≥70 years, community-dwellers
followed-up for 2 years (2010–2012). Exposure at
baseline: Five multimorbidity measures (disease
counts, selected conditions counts, Charlson
comorbidity index, RxRisk-V, medication counts)
calculated using GP medical record and linked national
pharmacy claims data.
Primary outcomes: (1) Emergency admission and
ambulatory care sensitive (ACS) admission (GP
medical record) and (2) functional decline (postal
questionnaire).
Statistical analysis: Descriptive statistics and
measure discrimination (c-statistic, 95% CIs), adjusted
for confounders.
Results: Median age was 77 years and 53% were
women. Prevalent rates ranged from 37% to 91%
depending on which measure was used to define
multimorbidity. All measures demonstrated poor
discrimination for the outcome of emergency
admission (c-statistic range: 0.62, 0.65), ACS
admission (c-statistic range: 0.63, 0.68) and functional
decline (c-statistic range: 0.55, 0.61). Medication-
based measures were equivalent to diagnosis-based
measures.
Conclusions: The choice of measure may have a
significant impact on prevalent rates. Five
multimorbidity measures demonstrated poor
discrimination in predicting emergency admission and
functional decline, with medication-based measures
equivalent to diagnosis-based measures. Consideration
of multimorbidity in isolation is insufficient for
predicting these outcomes in community settings.
INTRODUCTION
Characterising the impact of multimorbidity,
deﬁned as the presence of two or more
chronic medical conditions in an individual,
in predicting poorer health outcomes for
community-dwelling older people has
emerged as an important concept in the last
decade.1 A challenge is deciding which mul-
timorbidity measure to use in research and
clinical practice. Several measures have been
developed and tested , including, most com-
monly, simple disease counts, the Charlson
comorbidity index and the Adjusted Clinical
Groups (ACG) system.2 However, primary
care research comparing different measures
for relevant patient outcomes is relatively
Strengths and limitations of this study
▪ Comparison of five count-based measures of
multimorbidity in predicting emergency admis-
sion and functional decline.
▪ The prospective study design and calculation of
the medication exposure using linked pharmacy
claims data are strengths of this study. Some
previous studies have been limited by study
design (cross-sectional) and data available (eg,
self-report).
▪ This study is set in primary care, which is
important as many studies to date have been
conducted in secondary care.
▪ A small number (n=21, 3%) of study participants
had some missing data for the outcome measure
of functional decline and were excluded.
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limited. To date, studies have largely focused on mortal-
ity and cost outcomes with methodological limitations
(eg, cross-sectional study design) and using a narrow
deﬁnition of multimorbidity (eg, index chronic condi-
tion plus another condition), therefore reducing gener-
alisability.3–8
A systematic review concluded that diagnosis-based
measures (eg, disease counts) perform best in predict-
ing mortality outcomes, whereas medication-based
indices (eg, RxRisk-V) demonstrated better predictive
accuracy for healthcare usage.9 However, these ﬁndings
were largely based on the application of individual mea-
sures in different populations rather than direct com-
parison of measures in the same population.9 In
addition, there is a paucity of research examining the
performance of different multimorbidity measures in
predicting other relevant outcomes, such as emergency
admission and functional decline.
Using a count-based approach, such as simple disease
or medication counts, in measuring multimorbidity has
several advantages in that it is reasonably simple to apply
and replication is more straightforward, important for
achieving consistent deﬁnitions of multimorbidity across
research studies. The aim of this study was to compare
the performance of different count-based measures of
multimorbidity in predicting emergency hospital admis-
sion and functional decline in older community-dwelling
adults attending primary care.
METHODS
The STrengthening the Reporting of Observational
Studies in Epidemiology (STROBE) guidelines were
adhered to in the conduct and reporting of this cohort
study.10 This study was a secondary analysis of prospect-
ively collected data examining the association between
potentially inappropriate prescribing and adverse health
outcomes in older people.
Study design and study population
This is a 2-year prospective cohort study of older
community-dwelling patients recruited from 15 general
practices (GP) in Ireland (2010–2012). At baseline in
2010, a proportionate stratiﬁed random sampling
approach was used to recruit patients for study participa-
tion. Study inclusion criteria were: (1) age ≥70 years on
1 January 2010 and (2) in receipt of a valid general
medical services (GMS) card. Approximately 96% of
people aged ≥70 years are in receipt of a GMS card
which provides free access to public health services and
prescribed medications, subject to a maximum copay-
ment of €25 monthly.11
The following exclusion criteria were applied: (1)
receiving palliative care; (2) cognitive impairment at the
level that would affect their ability to complete the
outcome measure (deﬁned as Mini Mental State
Examination ≤20); (3) signiﬁcant hearing/speech/
visual impairment; (4) currently experiencing a
psychotic episode; (5) hospitalised long-term, in a
nursing home, homeless or in sheltered accommoda-
tion; and (6) recent bereavement (within 4 weeks). Each
participant’s GP applied the exclusion criteria and deter-
mined eligibility for participation at baseline and at
follow-up.
Exposure of interest: measures of multimorbidity
All exposures of interest were measured at baseline
(2010) using the GP medical record to identify medical
diagnoses and linked data from the national pharmacy
claims database to determine prescribed medications.
Total disease counts
This measure involves a simple count of chronic medical
conditions. Chronic medical conditions were recorded
from the GP electronic medical record over a prespeci-
ﬁed 6-month period. The International Classiﬁcation of
Primary Care (ICPC-2) deﬁnition of a chronic disease
was used.12 Multimorbidity was deﬁned as the presence
of two or more chronic medical conditions in an
individual.13
Selected conditions disease count
Barnett et al14 developed a set of 40 chronic medical
conditions for inclusion when measuring multimorbidity
using a large Scottish primary care cohort (n=1.75
million adults). Chronic conditions were selected based
on health impact and prevalence. For morbidities with
lifelong implications (eg, congestive heart failure), the
presence of the condition was on the basis of it ever
being recorded in the GP record. However, for other
conditions where lifelong remission/cure is possible, the
morbidity had to be recorded in a deﬁned period (eg,
cancer in the previous 5 years) or in terms of relevant
prescribing (eg, epilepsy currently treated).14
Multimorbidity was deﬁned as the presence of two or
more of these speciﬁed conditions.
Charlson comorbidity index
This measure was developed in an inpatient US popula-
tion to predict mortality and includes 19 conditions that
have been selected and weighted in relation to their
association with mortality risk.15 Medical conditions
recorded from the GP record were reviewed and each
study participant was assigned a score based on the com-
ponents of the index.
Number of dispensed medication classes
This measure was a count of the number of dispensed
medication classes and was calculated using linked phar-
macy claims data from the national Health Services
Executive (HSE)-Primary Care Reimbursement
Scheme (PCRS) pharmacy claims database. This data-
base has complete coverage for medications dispensed
to patients with a GMS card. Patients gave consent for
their pharmacy claims data to be linked to their unique
GMS number. In the HSE-PCRS, dispensed prescriptions
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are coded using the WHO Anatomical Therapeutic
Chemical (WHO-ATC) classiﬁcation system and deﬁned
daily doses, strength, quantity of medication and mode
of administration is available. Polypharmacy was deﬁned
as the concurrent prescription of ≥4 medications and
high-risk polypharmacy as ≥10 medications.9
RxRisk-V
The RxRisk-V was developed speciﬁcally for older
people and classiﬁes patients’ chronic medical condi-
tions based on the WHO-ATC medication classiﬁcation
system of their dispensed medications.16 In validation
studies, the RxRisk-V has demonstrated criterion validity
and reliability when compared to patients’ medical diag-
noses.2 The RxRisk-V was calculated using the linked
HSE-PCRS pharmacy claims data.
Outcomes
Emergency admission
Emergency admission was deﬁned as ‘unplanned over-
night stay in hospital’ and was recorded from review of
each participant’s GP electronic medical record.17 The
number of emergency admissions, reason for admission
and length of hospital stay were recorded over 2 years of
follow-up (2010–2012). In addition, ambulatory care sen-
sitive (ACS) admissions were identiﬁed. These are a
subset of all emergency admissions that occur due to
select medical conditions (eg, asthma, congestive heart
failure and cellulitis) that are considered more amen-
able to prevention through primary care management.18
A list of included ACS conditions is provided in online
supplementary appendix 1.
Functional decline
The short functional survey (SFS), a subset of the
Vulnerable Elders Survey (VES-13), was used as the
measure of functional status.19 The VES-13 was devel-
oped in 1993 in an older Medicare population in the
USA to predict functional decline and death over
2 years.19 It includes items relating to age, self-rated
health, physical function and the SFS. The SFS com-
prises ﬁve questions relating to personal care, mobility
and activities of daily living and has been validated to
predict functional decline with similar accuracy as the
longer 12-item Activities of Daily Living scale.20
Disability in the activity was deﬁned as ‘having difﬁ-
culty and receiving help to perform the activity’ or ‘not
doing the activity due to their health’. Functional ability
was assumed for all other possible responses to the ques-
tions (‘no difﬁculty’, ‘difﬁculty but does not receive
help’ or ‘not doing the activity but for reasons other
than health’). Disability in each item was awarded a
score of 1, so a person unable to complete all ﬁve tasks
was scored 5. Functional decline was deﬁned as an
increase in the SFS score by ≥1 point between baseline
and follow-up. In addition, any study participant who
entered a nursing home during the follow-up was also
considered to have experienced functional decline.
Confounding variables
Age, gender and deprivation were included in adjusted
analyses, in keeping with previous studies.8 21 Age and
gender were determined from the GP medical record.
Each patient’s address was geocoded according to electoral
division and patient deprivation was estimated from the
deprivation score of the patient’s address. This approach is
based on the Small Area Health Research Unit (SAHRU),
which shares similarities with the Townsend and Carstairs
deprivation indices widely used in the UK.22
Statistical analysis
Baseline descriptive statistics of the cohort are described.
The performance of each measure was assessed by investi-
gating the discrimination (equivalent to the area under
the receiving operating characteristic (ROC) curve). This
score ranges from 0 to 1, where a value of 0.5 represents
the same performance as chance, 0.5–0.7 represents
poor model discrimination, 0.7–0.9 represents reasonable
discrimination and ≥0.9 represents excellent discrimin-
ation.23 Discrimination was assessed using the non-
parametric method by calculating a c-statistic with 95%
CIs for each measure considered as continuous variables.
Different cut-points within the same measure were then
examined to determine which offered optimal discrimin-
ation for the outcome of interest (eg, 0 conditions vs 1
condition, 0–1 conditions vs 2 conditions etc). Once the
optimal cut-point was established for each measure, all ﬁve
measures were then compared to examine which offered
the best discrimination for each of the outcomes of inter-
est. These measures were then adjusted for age, gender
and deprivation to see how this impacted overall predictive
accuracy. A series of ROC plots were generated to examine
visually the differences between the measures in predict-
ing the outcomes of interest. Model goodness of ﬁt was
assessed using the Hosmer-Lemeshow statistic. All analyses
were conducted using Stata V.13. (StataCorp, Texas, USA)
RESULTS
Baseline characteristics
Of 904 baseline study participants, 862 (95%) were
included in this 2-year follow-up study (see table 1).
Median age was 77 years and 53% were women.
Participants were excluded if there was incomplete hos-
pital admission data for the follow-up period as follows:
19 moved GP practice; 14 moved to a nursing home;
and 9 GP medical record reviews were missing. A sensi-
tivity analysis was also conducted, excluding participants
who had died during the follow-up (n=53), which made
no appreciable difference to the overall results.
Exposure: multimorbidity measures
The prevalence of patients with multimorbidity as
deﬁned by each of the ﬁve multimorbidity measures is
presented in table 2.
A total of 626 (73%) patients met the deﬁnition for
multimorbidity according to the total disease counts
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measure and 484 (56%) according to the selected condi-
tion count measure. Three hundred and fourteen study
participants (37%) had ≥2 of the Charlson index condi-
tions, 789 (91%) ≥2 RxRisk-V conditions and 73%
(n=632) prescribed ≥4 medications with 13% (n=119)
prescribed ≥10 medications.
Outcome: (1) Emergency admission
Descriptive statistics
A total of 246 study participants (29%) were admitted as
an emergency at least once during the 2-year follow-up.
Of these, 159 (18%) were admitted once, 56 (7%) were
admitted twice and 31 (4%) were admitted ≥3 times. A
total of 110 (13%) had an ACS emergency admission.
Fifty-three study participants (6%) died during the
follow-up.
Overall unadjusted and adjusted c-statistics (95% CIs)
are presented in table 3.
All measures had similar adjusted predictive accuracy
(c-statistic range: 0.62 to 0.65) for emergency admission.
The selected condition count (c-statistic: 0.63 (95% CI
0.57 to 0.69)) and the RxRisk-V (c-statistic: 0.63 (95% CI
0.56 to 0.69)) demonstrated the greatest predictive
accuracy for this outcome. For ACS admission, overall
measure performance was marginally better (c-statistic
range: 0.63 to 0.68). The Charlson index (c statistic: 0.67
(95% CI 0.58 to 0.75), RxRisk-V (c-statistic: 0.67 (95%
CI 0.61 to 0.73) and medication count (c-statistic: 0.67
(95% CI 0.59 to 0.75) all demonstrated similar poor
predictive accuracy for this outcome.
Determining an optimal measure cut-point for emergency
admission
c-Statistics at different cut-points for emergency admis-
sion are presented in online supplementary ppendix 2.
The optimal count cut-points were: (1) RxRisk-V ≥6; (2)
number of medications ≥6; (3) disease count ≥3; (4)
selected condition count ≥2; and (5) Charlson index ≥1.
These ﬁve measures at their optimal cut-points and
adjusted for age, gender and deprivation were then com-
pared for the outcome of emergency admission. Overall,
there was no statistically signiﬁcant difference between
any of the ﬁve measures for predicting emergency admis-
sion (p=0.24) (see online supplementary appendix 3).
Identical statistical analysis was conducted for the
outcome of ≥1 ACS emergency admissions and c-statistics
for different cut-points. Overall, there was no statistically
signiﬁcant difference between any of the measures for
predicting ACS admission (p=0.95) (see online
Table 1 Baseline characteristics of study participants’
(n=862)
Patient characteristic Median (IQR)
Age 77 (73, 81)
Deprivation 1.33 (−0.64, 3.04)
N (%)
Gender
Male 404 (47)
Female 458 (53)
Marital status*
Married 393 (45)
Separated/divorced 42 (5)
Widowed 278 (32)
Never married/single 148 (17)
Living arrangements
Husband/wife/partner 383 (44)
Family/relatives 110 (13)
Live alone 327 (38)
Other 42 (5)
Education†
Basic education 531 (62)
Upper and postsecondary 325 (38)
Social class
Unskilled 326 (38)
Skilled 536 (62)
*Marital status was missing for n=1.
†Education was missing for n=6.
Table 2 Number and percentage of study participants with medication-based and diagnosis-based measures of
multimorbidity defined as two or more conditions or medication classes (n=862)
RxRisk-V N (%)
Number of
medication
classes N (%)
Total
disease
counts N (%)
Barnett
conditions
count N (%)
Charlson
index
score N (%)
0 13 (2) 0 37 (4) 0 52 (6) 0 149 (17) 0 340 (39)
1 60 (7) 1 41 (5) 1 184 (21) 1 229 (27) 1 208 (24)
≥2 789 (91) ≥2 784 (91) ≥2 626 (73) ≥2 484 (56) ≥2 314 (37)
2 96 (11) 2 75 (9) 2 208 (24) 2 213 (25) 2 159 (19)
3 125 (15) 3 77 (9) 3 157 (18) 3 134 (16) 3 85 (10)
4 131 (15) 4 95 (11) 4 102 (12) 4 79 (9) 4 36 (4)
5 114 (13) 5 88 (10) 5 79 (9) 5 35 (4) 5 17 (2)
6 101 (12) 6 116 (14) 6 49 (6) ≥6 23 (2) ≥6 17 (2)
7 78 (9) 7 88 (10) 7 17 (2)
8 57 (7) 8 62 (7) ≥8 14 (2)
9 37 (4) 9 64 (7)
≥10 50 (5) ≥10 119 (13)
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supplementary appendix 4). The optimal count cut-points
were: (1) RxRisk-V ≥5; (2) number of medications ≥6; (3)
disease count ≥3; (4) selected condition count ≥2; and
(5) Charlson index ≥1. The ﬁve multimorbidity measures
at their optimal cut-points, adjusted for age, gender and
deprivation, were then compared for the outcome of ACS
admission (see online supplementary appendix 5).
Outcome: (2) Functional decline
Descriptive statistics
Of 791 patients eligible, a total of 673 (85%) patients
completed a postal questionnaire at the follow-up which
included the SFS. There were 21 (3%) with missing data
for ≥1 items of the SFS and these patients were
excluded from the analysis. A further 14 study partici-
pants had been admitted to a nursing home and were
considered to have experienced functional decline.
Therefore, the study sample was n=666. Online
supplementary appendix 6 presents the differences
between postal questionnaire respondents at follow-up
compared to non-respondents. Non-respondents were
older, were taking a greater number of medications and
were more socioeconomically deprived.
Of questionnaire respondents, a total of 56 (8.4%)
reported a decline in ≥1 of the SFS items at follow-up
compared to baseline. An additional 14 participants’
were admitted to a nursing home resulting in a total of
70 participants’ (10.5%) with functional decline. Overall
unadjusted and adjusted analyses for this outcome are
presented in table 4.
In unadjusted analysis, all measures demonstrated
poor discrimination (c-statistic range: 0.57 to 0.62).
Discrimination performance was poor and following
adjustment for age, gender and deprivation the best-
performing measure for this outcome was the RxRisk-V
(c-statistic: 0.61 (95% CI 0.55 to 0.67)).
Determining an optimal measure cut-point for functional
decline
c-Statistics at different cut-points for the outcome of
functional decline are presented in online
supplementary appendix 7. The optimal count cut-
points were as follows: (1) RxRisk-V ≥5, (2) number of
medications ≥5, (3) disease count ≥3, (4) selected con-
dition count ≥3 and (5) Charlson index ≥3. The per-
formance of measures at their optimal cut-points,
adjusted for age, gender and deprivation, were then
compared for the outcome of functional decline. There
was no statistically signiﬁcant difference between any of
the measures for predicting functional decline (p=0.40)
(see online supplementary appendix 8).
DISCUSSION
Principal findings
Different count measures of multimorbidity demon-
strated similar poor discrimination for the outcome of
Table 3 Comparison of multimorbidity measures for outcomes of one or more emergency admission and one or more ACS
admission during the 2-year follow-up (n=862)
Model* ≥1 emergency admission ≥1 ACS admission
Multimorbidity
measure
c-statistic (95% CI)
unadjusted
c-statistic (95% CI)
adjusted†
c-statistic (95% CI)
unadjusted
c-statistic (95% CI)
adjusted†
Disease count 0.63 (0.59 to 0.66) 0.61 (0.54 to 0.68) 0.63 (0.57 to 0.69) 0.64 (0.57 to 0.71)
Barnett conditions
count
0.63 (0.60 to 0.66) 0.63 (0.57 to 0.69) 0.65 (0.58 to 0.71) 0.66 (0.59 to 0.73)
Charlson index 0.62 (0.59 to 0.65) 0.58 (0.54 to 0.63) 0.67 (0.63 to 0.71) 0.67 (0.58 to 0.75)
RxRisk-V 0.65 (0.61 to 0.69) 0.63 (0.56 to 0.69) 0.68 (0.62 to 0.73) 0.67 (0.61 to 0.73)
Number of
medications
0.65 (0.61 to 0.69) 0.62 (0.55 to 0.68) 0.68 (0.62 to 0.74) 0.67 (0.59 to 0.75)
*All measures are included as continuous variables.
†Adjusted for age, gender and deprivation.
NA, not applicable.
Table 4 Comparison of multimorbidity measures for the outcome of functional decline during the 2-year follow-up (n=666)
Model Functional decline Functional decline
Multimorbidity measure c-Statistic (95% CI), unadjusted c-Statistic (95% CI), adjusted
Disease count 0.59 (0.52 to 0.66) 0.55 (0.49 to 0.60)
Barnett conditions count 0.57 (0.52 to 0.63) 0.55 (0.50 to 0.59)
Charlson index 0.60 (0.53 to 0.68) 0.60 (0.53 to 0.67)
RxRisk-V 0.62 (0.55 to 0.69) 0.61 (0.55 to 0.67)
Number of medications 0.61 (0.52 to 0.70) 0.57 (0.48 to 0.66)
NA, not applicable.
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emergency admission in this study with the Rx-Risk-V
performing best (c-statistic: 0.63). Predictive accuracy for
ACS admission was marginally better and three measures
(RxRisk-V, number of medications and Charlson index)
demonstrated equivalent predictive accuracy (c-statistic
0.67). All measures demonstrated poor discrimination
for functional decline over 2-year follow-up (c-statistic
range: 0.55–0.61), indicating that measuring multimor-
bidity in isolation is insufﬁcient if aiming to predict
these outcomes.
Regarding multimorbidity prevalence, a total of 626
participants (73%) met the deﬁnition for multimorbid-
ity using the total disease counts measure and 484
(56%) according to the selected condition count
measure. Three hundred and fourteen (37%) had ≥2 of
the Charlson comorbidity index conditions. For medica-
tion count measures, a total of 789 participants (91%)
had ≥2 chronic RxRisk-V conditions and 73% (n=632)
met the deﬁnition for polypharmacy (≥4 medications)
with 13% (n=119) prescribed ≥10 medications (high-risk
polypharmacy). These ﬁndings indicate that multimor-
bidity prevalence in this older community-based cohort
varies considerably depending on the measure selected
to deﬁne it. Considering more than one drug will often
be needed to treat a single condition, it seems clinically
intuitive that a higher medication count is required to
deﬁne multimorbidity.
Comparison with existing literature
Few primary care studies have compared the perform-
ance of different multimorbidity measures for the
outcome of emergency admission. One US study (n=14,
192 adult veterans) reported similar performance of the
RxRisk, Charlson index and ACG system in predicting
hospital admission (c-statistic range: 0.61–0.64).24
Additional US population-based studies found that the
RxRisk-V predicted future healthcare use better than
diagnosis-based measures.16 25 A Canadian study, which
used administrative data (n=137, 700, aged ≥65 years)
and examined different measures of multimorbidity in
predicting hospital admission, reported only modest dis-
crimination for the best-performing measure of simple
disease counts (c-statistic 0.67).26 In the UK, a large-scale
cross-sectional study (n=95,372 adults) reported that
medication count was the more powerful predictor of
future primary care consultations when compared to
diagnosis-based measures.27
The current study adds to the literature in this area
and suggests that while all measures demonstrate poor
discrimination, medication-based measures, such as the
RxRisk-V, performed marginally better than diagnosis-
based measures in predicting emergency and ACS
admissions. For research purposes, these measures can
be applied to pharmacy claims databases rather than
requiring medical record review and simple medication
counts are easy to conduct in clinical practice. However,
it is important to highlight that emergency admission is
an inherently difﬁcult outcome to predict accurately.28
Existing admission risk prediction models, which
include a variety of clinical, socioeconomic and prior
healthcare usage variables, rarely achieve model discrim-
ination of ≥0.8, and the performance of the various
multimorbidity measures should be judged in this
context.29
There has been very limited research comparing the
performance of different multimorbidity measures in
predicting functional decline. One Italian study (n=633
aged ≥65 years) measured incident basic activities of
daily living (BADL) disability over 5-year follow-up.8 The
functional status was assessed using a modiﬁed version
of the Guralnik’s lower physical performance battery
and 9.6% developed incident disability. Disease counts
had the highest predictive value (c-statistic 0.85).8
However, all study participants had an index condition
of congestive heart failure which limits the generalisabil-
ity of this study to typical primary care populations.
Interestingly, a recent analysis argues that increasing
levels of multimorbidity in older people may be related
to increased diagnosis through screening and more vigi-
lant recording of diagnoses rather than worsening
health.30 This is supported by the fact that older
people’s self-rated health has not declined in tandem
with increasing morbidity levels.30 If this is the case,
then perhaps it is not surprising that count-based multi-
morbidity measures in isolation are not enough to
predict emergency admission and functional decline.
What is needed is a way of incorporating the burden
and severity of conditions into multimorbidity measures
to allow better capture of disease combinations that
predict poorer health outcomes.31 Research efforts to
conceptualise and capture the burden of multiple dis-
eases for patients are ongoing.32 33
Clinical and research implications
The current study indicates that the choice of measure
for multimorbidity will have implications in terms of
prevalence estimates. Using the cut-point of ≥2 to
deﬁne multimorbidity for the RxRisk-V measure would
result in almost the entire study population categorised
as multimorbid (91%), while using the selected condi-
tion list would identify a smaller proportion (56%).
Existing multimorbidity intervention studies have largely
used diagnosis-based inclusion criteria, with a smaller
number of studies using this approach in combination
with medication count.34 An example is the OPTIMAL
primary care randomised controlled trial that recruited
patients with two or more chronic conditions prescribed
four or more medications for a self-management inter-
vention that succeeded in improving activity participa-
tion.35 Using this combined approach seems pragmatic
and should ensure patients with more complex multi-
morbidity are included. Future research studies need to
carefully consider participant selection, choice of inter-
vention and relevant outcomes in community-based mul-
timorbidity trials.36
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A systematic review examining multimorbidity mea-
sures included in risk prediction models designed to
predict future hospital admission and readmission
reported that of 21 studies which included a multimor-
bidity measure, a total of 15 (71%) used the Charlson
comorbidity index (or adapted version).37 Only two
studies used a medication-based measure of multimorbid-
ity.37 The current study indicates that medication-based
measures may be considered for use in risk prediction
models with this outcome of interest. However, as men-
tioned, higher cut-points are needed to achieve optimal
discrimination.
Strengths and limitations
This prospective primary care study adds to the limited
literature in comparing different multimorbidity
measures to predict health outcomes for older
community-dwelling people. The study population was
not selected based on the presence of any one index
condition, which improves the generalisability of the
ﬁndings. The robustness of the multimorbidity measures
calculation is enhanced by diagnosis measurement using
GP electronic medical record data for and use of linked
pharmacy claims data for the medication-based mea-
sures. The outcomes of emergency admission and ACS
admission were recorded from review of the GP elec-
tronic medical record. ACS emergency admissions are
increasingly of interest due to their perceived prevent-
ability through primary care interventions. However,
only a limited number of risk prediction models have
been developed speciﬁcally to identify ACS admissions.29
Understanding which multimorbidity measure to
include preferentially in predicting ACS admission is
important and topical.
Regarding study limitations, the study involves 15
general practices from Ireland and as such may not be
generalisable to other settings. As one of the outcome
measurements depended on participants’ ﬁlling in a
postal questionnaire those with cognitive impairment at
the level that would impact their ability to complete the
outcome measure (deﬁned as Mini Mental State
Examination ≤20) were excluded from this study which
may also affect on generalisability of the ﬁndings.
Accuracy of diagnosis information was dependent on
accurate recording of information taken from the GP
electronic medical record. All GP medical record data
was recorded by the same researcher and a random
sample of 10% of all data was double checked by an
independent reviewer with extensive data cleaning
undertaken to maximise accuracy and reducing the like-
lihood of misclassiﬁcation bias. A small number (n=21,
3%) of study participants had some missing data for the
outcome measure of functional decline and were
excluded.8
Conclusions
This study indicates that though all multimorbidity mea-
sures demonstrate poor discrimination, medication-
based measures are equivalent to diagnosis-based mea-
sures in predicting emergency admission. The choice of
multimorbidity measure used may have a signiﬁcant
impact on prevalence. Consideration of multimorbidity
in isolation is insufﬁcient in predicting which primary
care patients are most likely to experience emergency
admission or functional decline.
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